Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;90(3):311-317.
doi: 10.1007/s12185-009-0412-4. Epub 2009 Sep 2.

Suppressed neutrophil function in children with acute lymphoblastic leukemia

Affiliations

Suppressed neutrophil function in children with acute lymphoblastic leukemia

Fumiko Tanaka et al. Int J Hematol. 2009 Oct.

Abstract

Infection is a major obstacle in cancer chemotherapy. Neutropenia has been considered to be the most important risk factor for severe infection; however, other factors, such as impaired neutrophil function, may be involved in susceptibility to infection in patients undergoing chemotherapy. In this study, we analyzed neutrophil function in children with acute lymphoblastic leukemia (ALL). Whole blood samples were obtained from 16 children with ALL at diagnosis, after induction chemotherapy, and after consolidation chemotherapy. Oxidative burst and phagocytic activity of neutrophils were analyzed by flow cytometry. Oxidative burst of neutrophils was impaired in ALL patients. The percentage of neutrophils with normal oxidative burst after PMA stimulation was 59.0 +/- 13.2 or 70.0 +/- 21.0% at diagnosis or after induction chemotherapy, respectively, which was significantly lower compared with 93.8 +/- 6.1% in healthy control subjects (P = 0.00004, or 0.002, respectively); however, this value was normal after consolidation chemotherapy. No significant differences were noted in phagocytic activity in children with ALL compared with healthy control subjects. Impaired oxidative burst of neutrophils may be one risk factor for infections in children with ALL, especially in the initial periods of treatment.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Lab Clin Med. 1981 Sep;98(3):374-81 - PubMed
    1. J Immunol. 2006 Nov 15;177(10):7155-63 - PubMed
    1. Leuk Lymphoma. 2004 Aug;45(8):1617-21 - PubMed
    1. Cancer. 2005 Mar 1;103(5):1054-63 - PubMed
    1. Clin Chim Acta. 2003 May;331(1-2):103-10 - PubMed

MeSH terms

LinkOut - more resources